Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of Concern

Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of Concern

The global coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spawned an ongoing demand for new research reagents and interventions. Herein we describe a panel of monoclonal antibodies raised against SARS-CoV-2. One antibody sh...

Full description

Bibliographic Details
Main Authors: Mahali S. Morgan, Kexin Yan, Thuy T. Le, Ryan A. Johnston, Alberto A. Amarilla, David A. Muller, Christopher L. D. McMillan, Naphak Modhiran, Daniel Watterson, James R. Potter, Julian D.J. Sng, Mary Lor, Devina Paramitha, Ariel Isaacs, Alexander A. Khromykh, Roy A. Hall, Andreas Suhrbier, Daniel J. Rawle, Jody Hobson-Peters
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Viruses
Subjects:
monoclonal antibody
SARS-CoV-2
immunohistochemistry
immunofluorescence
Western blotting
lateral flow assays
Online Access:https://www.mdpi.com/1999-4915/15/1/139

Internet

https://www.mdpi.com/1999-4915/15/1/139

Similar Items